-
Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical hodgkin lymphoma: The HOVON/LLPC transplant brave study
Hagenbeek, A., Mooij, H., Zijlstra, J., Lugtenburg, P., van Imhoff, G., Nijland, M., Tonino, S., Hutchings, M., Spiering, M., Liu, R., van Tinteren, H. & Kersten, M. J., 31 Mar 2019, In: Haematologica. 104, 4, p. e151-e153Research output: Contribution to journal › Letter › Academic › peer-review
-
Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma
JULIET Investigators, 3 Jan 2019, In: New England journal of medicine. 380, 1, p. 45-56 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Final results of a phase 1b study of the safety and efficacy of the PI3Kδ inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies
Kater, A. P., Tonino, S. H., Spiering, M., Chamuleau, M. E. D., Liu, R., Adewoye, A. H., Gao, J., Dreiling, L., Xin, Y., Doorduijn, J. K. & Kersten, M. J., 2018, In: Blood Cancer Journal. 8, 2, p. 16 16.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications